Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Clearside Biomedical Inc.
CLMCurrent price
0.98 EUR
-0.045 EUR (-4.41%)
Last closed
1.01 EUR
Company
www.clearsidebio.com
ISIN
US1850631045
Sector
Healthcare
Industry
Biotechnology
Exchange
Stuttgart Exchange
Capitalization
79 855 143 EUR
Yield for 12 month
+12.72 %
1Y
3Y
5Y
10Y
15Y
CLM
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Address: 900 North Point Parkway, Alpharetta, GA, United States, 30005
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
11.01 EURP/E ratio
–Dividend Yield
–Current Year
+7 807 790 EUR
Last Year
+1 259 535 EUR
Current Quarter
+85 424 EUR
Last Quarter
+218 307 EUR
Current Year
+7 470 838 EUR
Last Year
+1 065 907 EUR
Current Quarter
+85 424 EUR
Last Quarter
–
Key Figures CLM
1 year
3 years
5 years
10 years
EBITDA
-25 957 960 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-44.05 %
PEG Ratio
–
Return On Equity TTM
-1310.02 %
Wall Street Target Price
11.01 EUR
Revenue TTM
7 611 368 EUR
Book Value
-0.38 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-91.2 %
Dividend Yield
–
Gross Profit TTM
1 136 040 EUR
Earnings per share
-0.47 EUR
Diluted Eps TTM
-0.47 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CLM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CLM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CLM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
7.5376
Price Sales TTM
10.4916
Enterprise Value EBITDA
-2.6481
Price Book MRQ
3.9681
Financials CLM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CLM
For 52 weeks
0.82 EUR
1.85 EUR
50 Day MA
1.05 EUR
Shares Short Prior Month
–
200 Day MA
1.14 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart